Advantagene, Inc. — Form D/A
Advantagene, Inc. of AUBURNDALE, MA, a company, filed a Form D amendment with the SEC on 2016-07-13. The offering totals $35.0M, of which $12.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-07-13
- Form: D/A
- Accession: 0001660549-16-000006
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $12.9M
- Remaining: $22.1M
- Investors: 230
- Date of first sale: 2016-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-261703
Issuer
- Name: Advantagene, Inc.
- CIK: 0001660549
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 440 LEXINGTON STREET, AUBURNDALE, MA, 02466
- Phone: 617-916-5445
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Stephen C Rocamboli | Executive Officer | Hummelstown, PA |
| Edward J Benz | Director | Greenwich, CT |
| Alan C Smith | Director | Auburndale, MA |
| Chris C Martell | Director | Auburndale, MA |
| Estuardo Aguilar-Cordova | Director | Auburndale, MA |
| Estuardo Aguilar-Cordova | Executive Officer | Auburndale, MA |
| Paul C Manning | Director | Auburndale, MA |
| Sean C Stalfort | Director | Auburndale, MA |
| Udi C Merav | Director | Auburndale, MA |
| Laura Aguilar | Executive Officer | Auburndale, MA |
| Glenn C Mattes | Director | Auburndale, MA |
| Mitchell C Finer | Director | Auburndale, MA |
| Fred C Mermelstein | Director | Auburndale, MA |
Other filings by this issuer (6)
More